20 May 2013
Keywords: Biogen Idec, Framework for Growth, Progress, Tysabri, Multiple sclerosis
Article | 13 January 2011
“Biogen Idec’s business fundamentals are strong – and we are building on those strengths to transform the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.